- Pascal Biosciences (OTC:BIMUF) and S?RSE Technology have entered into a Collaborative Research Agreement to advance Pascal’s PAS-393 into clinical testing.
- More news on: Pascal Biosciences Inc., Healthcare stocks news, Read more ...
home / stock / bimuf / bimuf news
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Biommune Technologies Inc Company Name:
BIMUF Stock Symbol:
Market:
VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise. First,...
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences,...